Vienna, Austria
July 03, 2018
:
APEIRON Biologics AG, a company focused on cancer immunotherapy has announced the signing of an agreement with the Institute of Molecular Biotechnology GmbH (IMBA) of the Austrian Academy of Sciences and the Medical University of Vienna (MedUni Wien).
Arlington
July 02, 2018
:
The statistics on osteoporosis-related bone breaks are alarming and will only get worse as the Baby Boomer population continues aging.
Cambridge, Mass
July 02, 2018
:
The Broad Institute of MIT and Harvard and Bayer are launching the Precision Cardiology Laboratory (PCL), a new endeavor that will pursue scientific insights aimed at developing new therapies for heart failure.
Silver Spring, MD
July 02, 2018
:
Opioid addiction and abuse remains an immense public health crisis. We're committed to continuing to take new steps to address these protracted dangers from every possible angle.
Indianapolis
June 30, 2018
:
Eli Lilly and Company will announce its financial results for the second quarter of 2018 on Tuesday, July 24, 2018. Lilly will also conduct a conference call on that day with the investment community and media to
Paris and Camberley
June 29, 2018
:
Novacyt, an international specialist in clinical diagnostics, announced that its protein diagnostics division, Lab21 Products (Lab21), has unconditionally entered into an asset purchase agreement to acquire the
London, UK, Carlsbad, CA
June 28, 2018
:
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary
Nottingham, UK
June 27, 2018
:
Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, is continuing its strategic investment in oral
Shanghai and Cambridge
June 27, 2018
:
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Harbour BioMed
Indianapolis
June 26, 2018
:
Eli Lilly and Company recently announced the successful completion of its acquisition of ARMO BioSciences. Lilly's tender offer for all outstanding shares of common stock of ARMO, at a price of $50.00 per